Trial
NCT03506048
Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Eisai Inc.
Condition
Differentiated Thyroid Gland Carcinoma
Intervention
Lenvatinib
Why stopped
Study has been abandoned for lack of accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-10